Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct 1;76(10):725-746.
doi: 10.1093/nutrit/nuy032.

Progress and perspectives in plant sterol and plant stanol research

Affiliations
Review

Progress and perspectives in plant sterol and plant stanol research

Peter J H Jones et al. Nutr Rev. .

Abstract

Current evidence indicates that foods with added plant sterols or stanols can lower serum levels of low-density lipoprotein cholesterol. This review summarizes the recent findings and deliberations of 31 experts in the field who participated in a scientific meeting in Winnipeg, Canada, on the health effects of plant sterols and stanols. Participants discussed issues including, but not limited to, the health benefits of plant sterols and stanols beyond cholesterol lowering, the role of plant sterols and stanols as adjuncts to diet and drugs, and the challenges involved in measuring plant sterols and stanols in biological samples. Variations in interindividual responses to plant sterols and stanols, as well as the personalization of lipid-lowering therapies, were addressed. Finally, the clinical aspects and treatment of sitosterolemia were reviewed. Although plant sterols and stanols continue to offer an efficacious and convenient dietary approach to cholesterol management, long-term clinical trials investigating the endpoints of cardiovascular disease are still lacking.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percent change in low-density lipoprotein cholesterol (LDL-C) from baseline in response to consumption of a low-fat soy beverage enriched with plant sterols (plant sterol intake, 1.95 g/d).
Figure 2
Figure 2
Proposed surrogate measure of cholesterol metabolism that could overcome issues related to the use of ratios of markers of surrogate synthesis to markers of absorption.
Figure 3
Figure 3
Correlations between changes in serum low-density lipoprotein cholesterol (LDL-C) and plasma plant sterols and changes in flow-mediated dilation (used with permission from Ras et al 164 ). Abbreviations: FMD, flow-mediated dilation; pp, percentage points

Similar articles

Cited by

References

    1. Plat J, Mackay D, Baumgartner S, et al. Progress and prospective of plant sterol and plant stanol research: report of the Maastricht meeting. Atherosclerosis. 2012;225:521–533. - PubMed
    1. Cicero AFG, Colletti A, Bajraktari G, et al. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Nutr Rev. 2017;75:731–767. - PubMed
    1. Malina DM, Fonseca FA, Barbosa SA, et al. Additive effects of plant sterols supplementation in addition to different lipid-lowering regimens. J Clin Lipidol. 2015;9:542–552. - PubMed
    1. Ward N, Sahebkar A, Banach M, et al. Recent perspectives on the role of nutraceuticals as cholesterol-lowering agents. Curr Opin Lipidol. 2017;28:495–501. - PubMed
    1. Rysz J, Franczyk B, Olszewski R, et al. The use of plant sterols and stanols as lipid-lowering agents in cardiovascular disease. Curr Pharm Des. 2017;23:2488–2495. - PubMed

Publication types

MeSH terms

Supplementary concepts